s6y

SciSparc Ltd.

Ticker
SPRC
CIK
1611746
Industry
Pharmaceutical Preparations
Formerly
SciSparc Ltd./ADR, Therapix Biosciences Ltd.

Financials 1

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Dec 31, 2018

Ownership 36

  1. 3/A Initial statement of beneficial ownership of securities
  2. 3/A Initial statement of beneficial ownership of securities
  3. 3/A Initial statement of beneficial ownership of securities
  4. 3/A Initial statement of beneficial ownership of securities
  5. 3/A Initial statement of beneficial ownership of securities
  6. 3/A Initial statement of beneficial ownership of securities
  7. 3/A Initial statement of beneficial ownership of securities
  8. 3/A Initial statement of beneficial ownership of securities
  9. 3/A Initial statement of beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 36 ownership filings

Prospectus 40

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. RW Registration Withdrawal Request
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  9. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  10. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

All 40 prospectus filings

Other 534

  1. EFFECT Notice of Effectiveness
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. F-3 Registration statement for specified transactions by certain foreign private issuers
  4. 6-K/A Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 534 other filings